Radiopharm Theranostics L... (RADX)
NASDAQ: RADX
· Real-Time Price · USD
5.08
-0.04 (-0.84%)
At close: Jun 17, 2025, 3:39 PM
5.71
12.33%
After-hours: Jun 17, 2025, 04:10 PM EDT
-0.84% (1D)
| Bid | 4.15 |
| Market Cap | 6.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -12.15 |
| PE Ratio (ttm) | -0.42 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 5.71 |
| Volume | 10,474 |
| Avg. Volume (20D) | 26,953 |
| Open | 5.08 |
| Previous Close | 5.12 |
| Day's Range | 5.08 - 5.17 |
| 52-Week Range | 3.50 - 50.82 |
| Beta | 0.84 |
About RADX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RADX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RADX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+4.9%
Radiopharm Theranostics shares are trading higher ...
Unlock content with
Pro Subscription
2 weeks ago
+11.18%
Radiopharm Theranostics shares are trading higher after the company announced preclinical data from studies with the Lu177-B7H3-monoclonal antibody RV01.